WC Walker & Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
WC Walker & Associates's AMGN Position: Q2 2021 in Review
WC Walker & Associates sold out of Amgen (AMGN) in Q2 2021, closing a stake of 7,264 shares — an estimated $1.81M sold.
WC Walker & Associates first reported a position in AMGN in Q4 2020 and held it in 2 quarters. The position peaked at $1.81M in Q1 2021. 2,194 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.
- WC Walker & Associates reported no remaining Amgen position as of Q2 2021 after selling out during the quarter.
- WC Walker & Associates sold 7,264 Amgen shares in Q2 2021, an estimated $1.81M.
- WC Walker & Associates first reported a position in Amgen in Q4 2020 and held it in 2 quarters.
- WC Walker & Associates's Amgen position peaked at $1.81M in Q1 2021.
- 2,194 funds tracked by Wall St. Rank held Amgen as of Q2 2021.
Based on WC Walker & Associates's 13F filing for Q2 2021, filed 6 Jul 2021.